Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Therapeutics

PROPPR Trial Supports Use of Transfusion Protocol Initially Developed for Battlefield Trauma Patients

In a groundbreaking multisite prospective clinical trial, the damage control resuscitation protocol for massive blood transfusion significantly improved severe trauma patient outcome from hemorrhagic shock, when compared to another commonly used protocol.  More...
04 Mar 2015

Alzheimer's Disease Symptoms Reversed for the First Time

Researchers at the Sunnybrook Research Institute, have found a way to reverse some of the symptoms of Alzheimer's disease, using Magnetic Resonance imaging-guided focused ultrasound.   More...
24 Feb 2015
Image:  Graphical summary of a new study showing that athletic performance (and therefore sport event outcome) also depends on the circadian rhythms of individual athletes (Photo courtesy of University of Birmingham and Cell Press).

Outcome of Sports Events May Depend on Circadian Rhythms

According to a new study, the outcome of sporting events may depend on how well the timing of the match aligns with the internal biological clocks of the athletes, and so could change performance by the hour depending on what time it is for their inner clock.   More...
10 Feb 2015

Reprogramming Stem Cells May Suppress Cancer after Radiotherapy

The body has developed strategies of purging defective stem cells. A new study has revealed that one of these ways is a “program” that makes stem cells damaged by radiation differentiate into other cells that can no longer survive forever.   More...
27 Jan 2015
Image: Cancer cells infected with tumor-targeted oncolytic virus (red). Green indicates alpha-tubulin, a cell skeleton protein. Blue is DNA in the cancer cell nuclei (Photo courtesy of Dr. Rathi Gangeswaran, Bart’s Cancer Institute).

Innovative “Viro-Immunotherapy” Designed to Kill Breast Cancer Cells

A leading scientist has devised a new treatment that employs viruses to kill breast cancer cells. The research could lead to a promising “viro-immunotherapy” for patients with triple-negative breast cancer, an aggressive type of the disease that currently has no targeted treatment options.   More...
21 Jan 2015

New Antibiotic Kills Pathogens Without Detectable Resistance

The first new antibiotic to be discovered in nearly 30 years could revolutionize the fight against the growing antibiotic resistance, claims a new study.  More...
20 Jan 2015

New Research Has Potential for Tackling Signs of Aging

A new biomedical research development has the potential to help with fighting diseases and conditions associated with aging, as well as in treating disease such as cancer.   More...
24 Dec 2014


BioResearch Therapeutics channel deals with all aspects of therapies beyond the five-year horizon.
 
Copyright © 2000-2015 Globetech Media. All rights reserved.